MesotheliomaHelp.org (blog)Nanoparticles Used to Awaken Immune System Faster May Lead To Mesothelioma ImmunotherapyMesotheliomaHelp.org (blog)Nanoparticles have been one of the most recent targets of cancer research for their ability to deliver anti-ca… Continue reading
Global Synthetic Biology Market Analysis 2018 DuPont, Integrated DNA Technologies, GenScript USA, Amyris and …Expert ConsultingThe report titled “Global Synthetic Biology Market” focuses on the performance of the Synthetic Biology market in terms of … Continue reading
Medical XpressOphthalmologists link immunotherapy with a serious eye conditionMedical XpressThe third patient with a uveal effusion continued with the immunotherapy for his melanoma, but he died four months later. Immune response in the eye. In the wal… Continue reading
Medical XpressOphthalmologists link immunotherapy with a serious eye conditionMedical XpressThe third patient with a uveal effusion continued with the immunotherapy for his melanoma, but he died four months later. Immune response in the eye. In the wal… Continue reading
Big Think (blog) |
Fasting For Just 24 Hours Boosts The Regeneration of Stem Cells, Study Finds
ScienceAlert In the study, that conversion didn’t just mean cells use up fat as an energy source instead of carbohydrates. Making the switch also enhanced their functioning. Intestinal stem cells, which the researchers describe as the “workhorses of the intestine … MIT study: 24-hour fasting regenerates stem cells, doubles metabolismBig Think (blog) |
Nasdaq |
FDA Grants Priority Review To Genentech’s Cancer Immunotherapy TECENTRIQ
Nasdaq (RTTNews.com) – Genentech, a member of the Roche Group ( RHHBY ), said that the U.S. Food and Drug Administration has accepted the company’s supplemental Biologics License Application or sBLA and granted Priority Review for TECENTRIQ or atezolizumab … FDA Grants Priority Review to Genentech’s Cancer Immunotherapy TECENTRIQ (Atezolizumab) for Initial Treatment of …Business Wire (press release) Roche’s Tecentriq combination to get speedy FDA reviewReuters |
Chemical & Engineering News |
Controlling CAR-T: How scientists plan to make the engineered T cell therapy safer, and work for more cancers
Chemical & Engineering News CAR T-cell therapy, a treatment that reprograms a person’s immune cells to attack cancer,works wonders for some people with rare blood cancers. But the highly personalized medicine also comes with risks: It can be extremely toxic and, in certain cases … |